◼ Archived
Business
🔮 Archynetys predicts: fades by tomorrow — graded ✓ correct
Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs
5sources
5articles
3velocity
+0%since first seen
21d agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (5)
- SCTX IPO News - Cardiovascular diseases biotech Scribe Therapeutics files for a $75 million IPO renaissancecapital.com · 22d ago
- Meet the gene-editing, cholesterol-fighting Alameda company looking for IPO riches The Business Journals · 22d ago
- Scribe Therapeutics files for proposed Nasdaq IPO By Investing.com Investing.com South Africa · 22d ago
- Scribe Therapeutics Stockholders Include Eli Lilly Moomoo · 22d ago
- Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs Endpoints News · 22d ago
Related trends
▲ Peaking
Business
Silicon Valley Is Completely Divided Over Chinese AI
▲ Peaking
Business
Waymo reportedly mulling a breakup with Uber
Waymo is reportedly exploring an end to its robotaxi partnership with Uber, signaling a potential shift in the competitive landscape of autonomous transport.
▲ Peaking
Business
Intel’s Strong Earnings Couldn’t Save the Stock From an AI Spending Panic
▲ Peaking
Business
New rental trend? Rental listing adds $200 'work-from-home fee'
A residential property listing in the Bay Area has sparked widespread debate by introducing a $200 monthly fee specifically for remote workers.
▲ Peaking
Business
Amazon cracks down on use of AI images by sellers after New York law
Amazon is mandating new AI disclosure rules for sellers to align with a recently enacted New York law regarding synthetic imagery.
▲ Peaking
Business
Stocks mixed as oil prices pause climb but yields hover near highs
Stock markets face uncertainty as rising oil prices and elevated yields reintroduce global inflation concerns.